1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Erectile Dysfunction (ED) Drugs Market
2.2. Global Erectile Dysfunction (ED) Drugs Market, By Drug, 2024 (US$ Million)
2.3. Global Erectile Dysfunction (ED) Drugs Market, By Distribution Channel, 2024 (US$ Million)
2.4. Global Erectile Dysfunction (ED) Drugs Market, By Geography, 2024 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2024

3. Erectile Dysfunction (ED) Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Erectile Dysfunction (ED) Drugs Market Vendors
3.2. Strategies Adopted by Erectile Dysfunction (ED) Drugs Market Vendors
3.3. Key Industry Strategies

4. Erectile Dysfunction (ED) Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Erectile Dysfunction (ED) Drugs Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Viagra
5.3.2. Cialis
5.3.3. Staxyn/Levitra
5.3.4. Stendra/Spedra
5.3.5. Others

6. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies


7. North America Erectile Dysfunction (ED) Drugs Market, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
7.3. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
7.4.Erectile Dysfunction (ED) Drugs Market: By Region, 2023-2033, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
7.4.1.1.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
7.4.1.2.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
7.4.1.3.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)

8. UK and European Union Erectile Dysfunction (ED) Drugs Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.3. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
8.4.Erectile Dysfunction (ED) Drugs Market: By Region, 2023-2033, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.4.1.1.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.4.1.2.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.4.1.3.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.4.1.4.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
8.4.1.5. France
8.4.1.5.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.4.1.5.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
8.4.1.6.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)

9. Asia Pacific Erectile Dysfunction (ED) Drugs Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.3. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
9.4.Erectile Dysfunction (ED) Drugs Market: By Region, 2023-2033, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.4.1.1.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.4.1.2.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
9.4.1.3. India
9.4.1.3.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.4.1.3.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.4.1.4.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.4.1.5.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
9.4.1.6.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)

10. Latin America Erectile Dysfunction (ED) Drugs Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
10.3. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
10.4.Erectile Dysfunction (ED) Drugs Market: By Region, 2023-2033, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
10.4.1.1.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
10.4.1.2.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
10.4.1.3.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)

11. Middle East and Africa Erectile Dysfunction (ED) Drugs Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
11.3. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
11.4.Erectile Dysfunction (ED) Drugs Market: By Region, 2023-2033, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
11.4.1.1.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
11.4.1.2.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Erectile Dysfunction (ED) Drugs Market: By Drug, 2023-2033, USD (Million)
11.4.1.3.2. Erectile Dysfunction (ED) Drugs Market: By Distribution Channel, 2023-2033, USD (Million)

12. Company Profile
12.1. Pfizer, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Dong-A ST Co., Ltd.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Eli Lilly and Company
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Bayer AG
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Vivus, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Teva Pharmaceutical Industries Ltd.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. SK Chemicals
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Meda Pharmaceuticals, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Cristalia Produtos Quimicos Farmaceuticos Ltda. Apricus Biosciences, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Futura Medical plc
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Other prominent players
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives